Country websites

Attention

For UK healthcare professionals (Nephrologists/Renal Nurses and Pharmacists) information only on Fresenius Medical Care’s medicines, medical devices, services, educational resources and more.

I'm a UK healthcare professional

Important notice – this site is intended for UK healthcare professionals only. By entering this site, and clicking on the button “Accepted and Confirmed”, you are confirming that you are a UK healthcare professional. In addition to educational resources, this site contains promotional information.

UK/HEMA/FME/0922/0005 Date of Preparation: November 2022

Acute blood purification

Offering renal care and beyond

Acute blood purification is based on extracorporeal treatment of blood and includes procedures to clean blood from toxins and pathogenic agents. Our main focus is on the treatment of acute kidney injury (AKI). It is founded on continuous kidney replacement therapy (CKRT), an extracorporeal procedure to slowly and still effectively clean blood from uremic toxins and other nitrogenous waste by making use of its ideally continuous application. This also includes managing fluid balance by low but sustained net ultrafiltration rates. CKRT is also known as CRRT, or continuous renal replacement therapy.

Reflecting our comprehensive multi-organ support approach, we further provide products and services that allow therapy diversity beyond CKRT, extracorporeal carbon dioxide removal (ECCO2R) in certain patients with acute respiratory dysfunction syndrome as well as therapeutic plasma exchange.

In CKRT, Fresenius Medical Care is committed to Ci‑Ca regional citrate anticoagulation. We were the first to offer a comprehensive Ci‑Ca therapy concept and product range, designed to improve anticoagulation in CKRT and reduce risks of bleeding complications.